Clinical trial
Decoding of the Expression of Tumor Suppressor P2RX7 in Inflammatory and Malignant Colonic Mucosa
NCT02293811 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Decoding of the Expression of Tumor Suppressor P2RX7 in Inflammatory and Malignant Colonic Mucosa
- Lead sponsor
- Centre Hospitalier Universitaire de Nice
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 9, 2015
- Completion date
- December 15, 2015
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
crohn disease-associated colorectal adenocarcinoma